Published: Guidance, quality standards and advice

Skip to filters Skip to results

Showing 651 to 675 of 2047

Sort by

Type: Guidance`Remove $Type: Guidance filter`

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapy	TA788	11 May 2022	11 May 2022
Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 and over	HST20	5 May 2022	5 May 2022
Liposuction for chronic lymphoedema	HTG622	27 April 2022	27 April 2022
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapies	TA786	27 April 2022	27 April 2022
Venetoclax with low dose cytarabine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable	TA787	27 April 2022	27 April 2022
Elosulfase alfa for treating mucopolysaccharidosis type 4A	HST19	20 April 2022	20 April 2022
Intramedullary distraction for upper limb lengthening	HTG621	20 April 2022	20 April 2022
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)	TA785	20 April 2022	20 April 2022
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer	TA784	20 April 2022	20 April 2022
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults	NG215	20 April 2022	20 April 2022
Daratumumab monotherapy for treating relapsed and refractory multiple myeloma	TA783	13 April 2022	13 April 2022
Stroke and transient ischaemic attack in over 16s: diagnosis and initial management	NG128	1 May 2019	13 April 2022
UroShield for preventing catheter-associated urinary tract infections	HTG620	31 March 2022	31 March 2022
Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment)	HTG619	30 March 2022	30 March 2022
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer	TA781	30 March 2022	30 March 2022
Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm (terminated appraisal)	TA782	30 March 2022	30 March 2022
Liposuction for chronic lipoedema	HTG618	29 March 2022	29 March 2022
Atidarsagene autotemcel for treating metachromatic leukodystrophy	HST18	28 March 2022	28 March 2022
Nivolumab with ipilimumab for untreated advanced renal cell carcinoma	TA780	24 March 2022	24 March 2022
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency	TA779	16 March 2022	16 March 2022
Integrated health and social care for people experiencing homelessness	NG214	16 March 2022	16 March 2022
Otitis media (acute): antimicrobial prescribing	NG91	28 March 2018	11 March 2022
Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitis	HTG617	9 March 2022	9 March 2022
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea	TA777	9 March 2022	9 March 2022
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria	TA778	9 March 2022	9 March 2022

Results per page

10
25
50
All